131 related articles for article (PubMed ID: 4155252)
1. Prolactin and human breast cancer.
Minton JP
Am J Surg; 1974 Nov; 128(5):628-30. PubMed ID: 4155252
[No Abstract] [Full Text] [Related]
2. Prolactin, F.S.H., and L.H. in breast cancer: effect of levodopa and oophorectomy.
Minton JP; Dickey RP
Lancet; 1972 May; 1(7759):1069-70. PubMed ID: 4112206
[No Abstract] [Full Text] [Related]
3. Proceedings: The response of breast cancer patients with bone pain to L-dopa.
Minton JP
Cancer; 1974 Feb; 33(2):358-63. PubMed ID: 4812755
[No Abstract] [Full Text] [Related]
4. Prognostic value of estrogen receptor to endocrine ablation in cancer of the breast.
Leung BS; Krippaehne WW; Fletcher WS
Surg Gynecol Obstet; 1974 Oct; 139(4):525-8. PubMed ID: 4138654
[No Abstract] [Full Text] [Related]
5. [Letter: L. Dopa and bone metastases in breast cancer].
Ghozian D; Amor B; Delbarre F
Nouv Presse Med; 1974 Mar; 3(11):678. PubMed ID: 4599794
[No Abstract] [Full Text] [Related]
6. Levodopa test to predict response of carcinoma of the breast to surgical ablation of endocrine glands.
Minton JP; Dickey RP
Surg Gynecol Obstet; 1973 Jun; 136(6):971-4. PubMed ID: 4703478
[No Abstract] [Full Text] [Related]
7. [Ablative endocrine treatment of advanced or metastasizing breast cancer. Criteria of patient selection].
Bocci A; Campagnoli C
Minerva Chir; 1976 Nov; 31(22):1371-6. PubMed ID: 1012556
[No Abstract] [Full Text] [Related]
8. [Hormonal therapy of metastizing breast cancer].
von Werder K
Med Klin; 1976 Feb; 71(8):313-21. PubMed ID: 56699
[No Abstract] [Full Text] [Related]
9. L-Dopa effect on prolactin, follicle-stimulating hormone, and luteinizing hormone in women with advanced breast cancer: a preliminary report.
Dickey RP; Minton JP
Am J Obstet Gynecol; 1972 Sep; 114(2):267-9. PubMed ID: 4635766
[No Abstract] [Full Text] [Related]
10. [Hormone dependence and the basis of hormone therapy in breast cancer].
Martin PM
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):183-99. PubMed ID: 209076
[No Abstract] [Full Text] [Related]
11. Prolactin, levodopa, and immune response in breast cancer.
Papaioannou AN
Lancet; 1972 Jul; 2(7770):226. PubMed ID: 4114225
[No Abstract] [Full Text] [Related]
12. [Estrogen receptors in breast cancers and endocrine therapy].
Maass H; Trams G; Nowakowski H
Strahlentherapie; 1974 Apr; 147(4):381-7. PubMed ID: 4369557
[No Abstract] [Full Text] [Related]
13. Hypothesis: breast cancer regression under oestrogen therapy.
Stoll BA
Br Med J; 1973 Aug; 3(5877):446-50. PubMed ID: 4353621
[TBL] [Abstract][Full Text] [Related]
14. Levodopa relief of bone pain from breast cancer.
Dickey RP; Minton JP
N Engl J Med; 1972 Apr; 286(15):843. PubMed ID: 5011796
[No Abstract] [Full Text] [Related]
15. Ablation therapy for hormone-dependent tumors.
Dao TL
Annu Rev Med; 1972; 23():1-18. PubMed ID: 4351952
[No Abstract] [Full Text] [Related]
16. Prolactin and breast cancer.
Lancet; 1972 Nov; 2(7787):1129-30. PubMed ID: 4117209
[No Abstract] [Full Text] [Related]
17. Prediction of breast cancer response to endocrine therapy.
DeSombre ER; Smith S; Block GE; Ferguson DJ; Jensen EV
Cancer Chemother Rep; 1974; 58(4):513-9. PubMed ID: 4369030
[No Abstract] [Full Text] [Related]
18. In vitro model systems for the study of hormone-dependent human breast cancer.
Lippman ME; Osborne CK; Knazek R; Young N
N Engl J Med; 1977 Jan; 296(3):154-9. PubMed ID: 187935
[No Abstract] [Full Text] [Related]
19. HORMONE THERAPY OF PATIENTS WITH ADVANCED CANCER OF THE BREAST.
SVIATUKHINA OV
Acta Unio Int Contra Cancrum; 1964; 20():518-20. PubMed ID: 14151975
[No Abstract] [Full Text] [Related]
20. Prolactin and breast carcinoma.
Smithline F; Sherman L; Kolodny D
N Engl J Med; 1975 Apr; 292(15):784-92. PubMed ID: 1089886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]